Paul Bleicher, MD, PhD
Paul Bleicher, MD, PhD, is a strategic advisor to OptumLabs.
Bleicher was formerly the CEO of OptumLabs since its inception. Prior to OptumLabs, he was chief medical officer for Humedica, a next-generation clinical informatics company. He also co-founded and was a leader at Phase Forward, which was instrumental in transforming pharmaceutical clinical trials from paper to the web.
Bleicher has served as a leader in industry organizations such as the National Academy of Medicine’s Leadership Consortium for Value & Science-Driven Health Care and the Drug Information Association. He has received numerous awards for his industry leadership.
Bleicher holds a BS from Rensselaer, as well as an MD and PhD from the University of Rochester School of Medicine and Dentistry. He began his career as a physician/investigator and assistant professor at the Massachusetts General Hospital and Harvard Medical School.